LW 50020

Drug Profile

LW 50020

Alternative Names: Luivac; LW-50050

Latest Information Update: 14 Nov 2007

Price : $50

At a glance

  • Originator Luitpold Pharmaceuticals
  • Class Antibacterials; Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 19 May 1999 A clinical study has been added to the Bacterial infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top